1-CHLORO-2-FLUORO-3-IODO-4-METHOXYBENZENE, 95.0%, 250mg

4-Chloro-2-(trifluoromethyl)quinoline>97.0%(GC)5g

tert-Butyl 4-(4-fluorobenzamido)piperidine-1-carboxylate, 95.0%, 1g

tert-Butyl 1-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridine-5(4H)-carboxylate, 97.0%, 1g

6,3-Glucuronolactone acetonide, 1g

2-{1-[(tert-butoxy)carbonyl]azetidin-3-yl}benzoic acid, 97%, 50mg

1,2-EPOXY-5-HEXENE, 95.0%, 5g

1-Bromo-2-ethylhexane>97.0%(GC)500mL

1-Nitro-4-[(4-nitrophenyl)dithio]benzene, 97.0%, 1g

1-(Tert-butyl)-4-(diethoxymethyl)-1H-1,2,3-triazole, 97%, 250mg

Ethyl 2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxylate, 98%, 5g

GC capillary column ROTI®Cap-5, 15 m, 0.53 mm, 1.00 µm, 1 Piece(s)

(S)-4-(tert-Butoxy)-2-isopropyl-4-oxobutanoic acid, 95.0%, 250mg